Method of preparing biologically active formulations
The invention provides pellet for use as a core for a pharmaceutical dosage form having an inner and an outer zone where the inner zone includes a biologically active agent and said outer zone includes a layer formed by applying a substantially dry, free flowing inert powder which forms a non-tacky surface when placed in contact with water. The invention also provides a process for making pharmaceutical pellets where the core or at least one a layer on the core is formed by (a) contacting powder particles, adhering them to each other and compacting the adhered pellets by a rolling movement, wherein the degree of densification is controlled by the rolling movement; and (b) feeding a sufficient amount of a substantially dry, free flowing inert powder which forms a non-tacky surface when placed in contact with water to provide on said particles an outer zone including a layer formed from said substantially dry, free flowing inert powder.
1. A pellet which is adapted for use as a core for a pharmaceutical dosage form, said pellet comprising:
an inner zone which is located in a center of the pellet, the inner zone being homogeneous and comprising a biologically active agent; and
an outer zone comprising: a substantially dry, free-flowing inert powder;
a swellable matrix forming polymer; and
and a non-swellable matrix forming polymer;
wherein the powder includes at least one component from the group consisting of microcrystalline cellulose, dicalcium phosphate, calcium sulfate, talc, an alkali metal stearate, silicon dioxide, and calcium carbonate;
wherein the swellable matrix forming polymer includes at least one component selected from the group consisting of hydroxypropyl methyl cellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, and carboxypolymethylene;
wherein the non-swellable matrix forming polymer includes at least one component selected from the group consisting of acrylic/methacrylic polymers and ethyl cellulose;
wherein the outer zone is formed on the inner zone without first drying the inner zone; and
wherein the pellet has a cross section which is visually homogeneous such that there is no visible distinction between the inner zone and the outer zone when viewed by a scanning electron microscope.
2. The pellet as defined in claim 1 ;
wherein the inner zone comprises:
0.1-95 wt % of one or more pharmaceutically acceptable components selected from the group consisting of binders and diluents; and
99.9-5.0 wt % of the biologically active agent.
3. The pellet as defined in claim 1 ;
wherein said outer zone further comprises from 0.1-99 wt % of a biologically active agent.
4. The pellet as defined in claim 1 ;
wherein the at least one component of the powder includes microcrystalline cellulose.
5. The pellet as defined in claim 1 ;
wherein said inner zone additionally comprises one or more components selected from the group consisting of lubricants, disintegrants, flavors, surfactants, anti-sticking agents, osmotic agents, and mixtures thereof.
6. The pellet as defined n claim 1 ;
wherein said outer zone additionally comprises one or more components selected from the group consisting of binders, diluents, disintegrants, lubricants, flavors, surfactants, anti-sticking agents, osmotic agents, and mixtures thereof.
7. The pellet as defined in claim 1 ;
wherein said inner comprises a swellable matrix forming polymer.
8. The pellet as defined in claim 1 ;
wherein said inner comprises a non-swellable matrix forming polymer.
9. The pellet as defined in claim 1 , further comprising:
one or more layers which comprise a release rate controlling polymer.
10. The pellet as defined in claim 9 ;
wherein the release rate controlling polymer comprises at least one component selected from the group consisting of ethyl cellulose, methacrylic acid copolymers, cellulose acetate phthalate, hydroxypropylmethylcellulose phthalate, hydroxypropylmethylcellulose acetate succinate, cellulose acetate trimellitate, and polyvinyl acetate phthalate.
11. A pharmaceutical dosage form which comprises:
coated pellets comprising:
as a core a pellet as defined in claim 1 ; and
one or more release rate controlling coatings selected from the group consisting of delayed release coatings, sustained release coatings, and mixtures thereof.
12. The pharmaceutical dosage form as defined in claim 11 ;
wherein the controlled release coating is a sustained release coating.
13. The pharmaceutical dosage form as defined in claim 11 ;
wherein the dosage form includes different populations of coated pellets having different controlled release coatings.
14. The pharmaceutical dosage form as defined in claim 11 ;
wherein the dosage form is a hard gelatin capsule.